Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-30

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating vedolizumab for chronic pouchitis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Pouchitis | Phase 4 | Status: COMPLETED | Results posted: 2021-06-30